Protagonist Therapeutics Inc (PTGX)

Receivables turnover

Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019
Revenue (ttm) US$ in thousands 315,090 60,137 123 123 982 26,704 35,221 45,507 46,913 27,380 24,330 27,139 31,091 28,549 25,678 12,604 6,408 4,321 3,955 10,051
Receivables US$ in thousands 50 51 3,852 620 3,363 28,504 5,333 4,509 9,855 5,819 3,821 3,324 3,273 3,747 7,499 2,118 6,310
Receivables turnover 2.46 19.25 6.93 56.81 13.53 1.65 5.13 5.40 2.75 5.34 7.47 7.73 3.85 1.71 0.58 1.87 1.59

March 31, 2024 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $315,090K ÷ $—K
= —

The receivables turnover ratio for Protagonist Therapeutics Inc has shown fluctuation over the past quarters, ranging from as low as 0.58 to as high as 56.81. A higher receivables turnover ratio indicates that the company is efficiently collecting its accounts receivable and converting them into cash.

In the latest quarter, the receivables turnover ratio was 2.46, which suggests that the company took approximately 2.46 times to collect its accounts receivable during the period. This figure is lower compared to the previous quarter's ratio of 19.25, indicating a decrease in the efficiency of the company in collecting receivables.

It is essential for Protagonist Therapeutics Inc to monitor its receivables turnover ratio consistently and aim to improve it over time to ensure timely collection of outstanding payments from customers and maintain healthy cash flow.


Peer comparison

Mar 31, 2024